Vital signs: Epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible staphylococcus aureus bloodstream infections - United States

Morbidity and Mortality Weekly Report

Volumn 68, Issue 9, 2019, Pages 214-219

  Kourtis, Athena P ^a   Hatfield, Kelly ^a   Baggs, James ^a   Mu, Yi ^a   See, Isaac ^a   Epson, Erin ^b   Nadle, Joelle ^c   Kainer, Marion A ^d   Dumyati, Ghinwa ^e   Petit, Susan ^f   Ray, Susan M ^g   Ham, David ^a   Capers, Catherine ^a   Ewing, Heather ^a   Coffin, Nicole ^a   McDonald, L Clifford ^a   Jernigan, John ^a   Cardo, Denise ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b California Department of Health   (United States)

^c CALIFORNIA EMERGING INFECTIONS PROGRAM   (United States)

^d Tennessee Emerging Infections Program   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f Connecticut Emerging Infections Program ^*  (United States)

^g Georgia Emerging Infections Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN;

BACTEREMIA; CROSS INFECTION; DRUG EFFECT; ELECTRONIC HEALTH RECORD; FACTUAL DATABASE; FEMALE; HEALTH SURVEY; HOSPITAL MORTALITY; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MORTALITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

BACTEREMIA; CROSS INFECTION; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 85062744001     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6809e1     Document Type: Article

References (32)

1. Magill SS, O’Leary E, Janelle SJ, et al.; Emerging Infections Program Hospital Prevalence Survey Team. Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med 2018;379:1732-44. https://doi.org/10.1056/NEJMoa1801550
2. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008;46(Suppl 5):S344-9. https://doi.org/10.1086/533590
3. Dantes R, Mu Y, Belflower R, et al.; Emerging Infections Program-Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013;173:1970-8.
4. CDC. Data summary of HAIs in the US: assessing progress 2006-2016. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/hai/data/archive/data-summary-assessing-progress.html
5. Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011;364:1419-30. https://doi.org/10.1056/NEJMoa1007474
6. CDC. 2016 national and state healthcare associated infections progress report. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/hai/data/portal/progress-report.html
7. US Department of Health and Human Services. National action plan to reduce health care-associated infections Washington, DC: US Department of Health and Human Services; 2010. https://health.gov/hcq/prevent-hai-action-plan.asp
8. Weiner LM, Webb AK, Walters MS, Dudeck MA, Kallen AJ. Policies for controlling multidrug-resistant organisms in US healthcare facilities reporting to the National Healthcare Safety Network, 2014. Infect Control Hosp Epidemiol 2016;37:1105-8. https://doi.org/10.1017/ice.2016.139
9. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007;44:471-82. https://doi.org/10.1086/511033
10. Wang JL, Chen SY, Wang JT, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008;46:799-806. https://doi.org/10.1086/527389
11. Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012;308:50-9. https://doi.org/10.1001/jama.2012.7139
12. Premier Applied Sciences. Premier healthcare database white paper: data that informs and performs. Charlotte, NC: Premier Applies Sciences; 2018. https://learn.premierinc.com/white-papers/premier-healthcare-database-whitepaper
13. DeShazo JP, Hoffman MA. A comparison of a multistate inpatient EHR database to the HCUP Nationwide Inpatient Sample. BMC Health Serv Res 2015;15:384. https://doi.org/10.1186/s12913-015-1025-7
14. American Hospital Association. AHA annual survey database Chicago, IL: American Hospital Association; 2017. http://www.ahadata.com
15. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725-32. https://doi.org/10.1056/NEJMoa061115
16. CDC. Reduction in central line-associated bloodstream infections among patients in intensive care units-Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005;54:1013-6.
17. CDC. Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011;60:243-8.
18. Perlin JB, Hickok JD, Septimus EJ, Moody JA, Englebright JD, Bracken RM. A bundled approach to reduce methicillin-resistant Staphylococcus aureus infections in a system of community hospitals. J Healthc Qual 2013;35:57-68.
19. Jones M, Ying J, Huttner B, et al. Relationships between the importation, transmission, and nosocomial infections of methicillin-resistant Staphylococcus aureus: an observational study of 112 Veterans Affairs medical centers. Clin Infect Dis 2014;58:32-9. https://doi.org/10.1093/cid/cit668
20. Jones M, Jernigan JA, Evans M, et al. Vital signs: trends in Staphylococcus aureus infections in Veterans Affairs medical centers-United States, 2005-2017. MMWR Morb Mortal Wkly Rep 2019;68(9).
21. See I, Albrecht V, Mu Y, et al. Changes in incidence and strains of methicillin-resistant Staphylococcus aureus bloodstream infections, 2005-2013 [abstract]. ID Week; Oct 26-30, 2016; New Orleans, LA.
22. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009;7:629-41. https://doi.org/10.1038/nrmicro2200
23. Huang SS, Singh R, McKinnell JA, et al. Decolonization to reduce postdischarge infection risk among MRSA carriers. N Engl J Med 2019; 380:638-50.
24. CDC. Methicillin-resistant Staphylococcus aureus (MRSA). Information for inpatient clinicians and administrators. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https://www.cdc.gov/mrsa/healthcare/clinicians/index.html
25. Klevens RM, Morrison MA, Nadle J, et al.; Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71. https://doi.org/10.1001/jama.298.15.1763
26. Jackson KA, Bohm MK, Brooks JT, et al. Invasive methicillin-resistant Staphylococcus aureus infections among persons who inject drugs-six sites, 2005-2016. MMWR Morb Mortal Wkly Rep 2018;67:625-8. https://doi.org/10.15585/mmwr.mm6722a2
27. Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies-tackling the opioid-overdose epidemic. N Engl J Med 2014;370:2063-6. https://doi.org/10.1056/NEJMp1402780
28. See I, Wesson P, Gualandi N, et al. Socioeconomic factors explain racial disparities in invasive community-associated methicillin-resistant Staphylococcus aureus disease rates. Clin Infect Dis 2017;64:597-604. https://doi.org/10.1093/cid/ciw808
29. Klein EY, Jiang W, Mojica N, et al. National costs associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010-2014. Clin Infect Dis 2019;68:22-8.
30. Rhee C, Dantes R, Epstein L, et al.; CDC Prevention Epicenter Program. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA 2017;318:1241-9. https://doi.org/10.1001/jama.2017.13836
31. Epstein L, Dantes R, Magill S, Fiore A. Varying estimates of sepsis mortality using death certificates and administrative codes-United States, 1999-2014. MMWR Morb Mortal Wkly Rep 2016;65:342-5. https://doi.org/10.15585/mmwr.mm6513a2
32. CDC. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidance documents. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://www.cdc.gov/hicpac/recommendations/index.html